Search results
UPCOMING DEADLINE ALERT: Biogen Inc. (Nasdaq: BIIB) Investors are Encouraged to Contact BFA Law...
Morningstar· 5 days agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities ...
Peapack Gladstone Financial Corp Sells 143 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoPeapack Gladstone Financial Corp decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.8% during the fourth quarter, according to its most recent filing ...
FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application...
Morningstar· 1 day agoTOKYO and CAMBRIDGE, Mass., June 9, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters ...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 20 hours agoA panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s...
Alzheimer’s drug from Eli Lilly wins backing of FDA committee
Washington Post· 4 hours agoAn advisory committee to the Food and Drug Administration on Monday endorsed an Alzheimer’s drug...
Petri Dish: Biogen has an airline partner; Takeda's new head of vaccines - Boston Business Journal
The Business Journals· 4 days agoSummer may have arrived in Massachusetts, but the biotech scene is still bustling. The companies...
Unanimous FDA panel backs Lilly Alzheimer's drug
Axios· 1 hour agoIt would compete with Eisai and Biogen's Leqembi, which the FDA approved last year. The FDA called for an outside review of donanemab earlier this year...
Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join – Contact The Gross...
Benzinga· 4 days agoThe Gross Law Firm issues the following notice to shareholders of Biogen Inc. BIIB. Shareholders who purchased shares of BIIB during the class period listed are encouraged ...
Alzheimer’s drug that can slow disease gets backing from FDA advisers - The Boston Globe
The Boston Globe· 1 hour agoThe FDA approved a similar infused drug, Leqembi, from Biogen and Japanese drugmaker Eisai, last year. In a separate vote, the FDA advisers voted unanimously that the Lilly ...
Lilly's Alzheimer's drug faces delayed reckoning
Axios· 13 hours agoThe outlook for the latest experimental drug shown to delay Alzheimer's disease will come into focus Monday, when Food and Drug Administration advisers...